Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents

被引:153
作者
Cryan, JF
Hoyer, D
Markou, A
机构
[1] Novartis Pharma AG, Neuromodulat Unit, Nervous Syst Res, CH-4002 Basel, Switzerland
[2] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA USA
关键词
depression; anhedonia; psychostimulant; amphetamine; withdrawal; animal model;
D O I
10.1016/S0006-3223(02)01730-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Amphetamine withdrawal and major depression share many behavioral commonalties in humans. Therefore, the examination of the behavioral effects of amphetamine withdrawal in rodents may provide insights into the neurobiological mechanisms underlying both disorders and aid in the development of animal models of depression that are sensitive to antidepressant agents. Methods: We examined the behavioral effects of withdrawal from chronic continuous infusion of amphetamine (via minipump) in three behavioral paradigms: the intracranial self-stimulation (ICSS) procedure in rats, the modified forced swim test in rats, and the tail suspension test in mice. Results: Amphetamine withdrawal resulted in a prolonged (5 day) deficit in brain reward function as assessed by elevations in ICSS thresholds. Using a similar regimen of amphetamine administration, we examined the behavioral affects of withdrawal in a modified rat forced swim test. Animals that were treated with the highest dose of amphetamine (10 mg/kg/day) exhibited increased climbing behavior and decreased immobility 24 hours after withdrawal; by the 48-hour testing time point, this effect had dissipated. In contrast, animals that had been pretreated with 5 mg/kg/day amphetamine exhibited a pronounced increase in immobility indicative of an increase in "depressive-like" behavior, coupled with decreases in swimming and climbing. In the mouse tail suspension test, both regimens of amphetamine pretreatment induced increases in immobility scores, also indicative of "depressive-like" behavior, 24 hours following withdrawal. Conclusions: Withdrawal from chronic amphetamine administration results in behavioral changes that may be analogous to some aspects of depression in humans, such as reward deficits (i.e., elevations in brain reward thresholds) and behaviors opposite to those seen after treatment with antidepressant drugs, such as decreased immobility in the forced swim test and the tail suspension test. Biol Psychiatry 2003;54:49-58 (C) 2003 Society of Biological Psychiatry.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 60 条
  • [1] Alonso SJ, 2000, J PHYSIOL BIOCHEM, V56, P77, DOI 10.1007/BF03179902
  • [2] Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test
    Anraku, T
    Ikegaya, Y
    Matsuki, N
    Nishiyama, N
    [J]. PSYCHOPHARMACOLOGY, 2001, 157 (02) : 217 - 220
  • [3] Intra- and interstrain differences in models of "behavioral despair"
    Bai, F
    Li, X
    Clay, M
    Lindstrom, T
    Skolnick, P
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (2-3) : 187 - 192
  • [4] A 'crash' course on psychostimulant withdrawal as a model of depression
    Barr, AM
    Markou, A
    Phillips, AG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (10) : 475 - 482
  • [5] Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat
    Blokland, A
    Lieben, C
    Deutz, NEP
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (01) : 39 - 49
  • [6] DISCOVERY OF ANTIDEPRESSANT ACTIVITY BY FORCED SWIMMING TEST MAY DEPEND ON PRE-EXPOSURE OF RATS TO A STRESSFUL SITUATION
    BORSINI, F
    LECCI, A
    SESSAREGO, A
    FRASSINE, R
    MELI, A
    [J]. PSYCHOPHARMACOLOGY, 1989, 97 (02) : 183 - 188
  • [7] cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs
    Conti, AC
    Cryan, JF
    Dalvi, A
    Lucki, I
    Blendy, JA
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (08) : 3262 - 3268
  • [8] Assessing antidepressant activity in rodents: recent developments and future needs
    Cryan, JF
    Markou, A
    Lucki, I
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) : 238 - 245
  • [9] Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test
    Cryan, JF
    Page, ME
    Lucki, I
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (03) : 197 - 205
  • [10] Cryan JF, 2000, J PHARMACOL EXP THER, V295, P1120